ReviewFrontiers in oncology2026

The mechanism of the PI3K-AKT-mTOR signaling pathway in renal cell carcinoma: current developments and future prospects.

Can Zou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.